Author Information
Lila Bouadma is a distinguished researcher affiliated with UMR 1137, IAME Team 5-DeScID: Decision Science in Infectious Diseases, Control and Care, INSERM/Université Paris Diderot, Sorbonne Paris Cité, Paris, France. Her research primarily focuses on infectious diseases, with a significant emphasis on critical care and the management of COVID-19. Her contributions to the field are well-recognized, particularly in the context of understanding and improving the care of patients with severe respiratory conditions.Research Contributions
Lila Bouadma has contributed significantly to the field of infectious diseases, with a particular focus on the management of COVID-19 and related respiratory conditions. Notable works include studies on the efficacy of treatments such as lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients, as well as investigations into healthcare-associated infections in intensive care units. Her research also explores the implications of invasive mechanical ventilation and the potential risks associated with type I interferon autoantibodies in COVID-19 patients. Bouadma's work has been pivotal in shaping clinical practices and policies during the pandemic.Aliases
Throughout her academic career, Lila Bouadma has been referenced by several aliases, including L Bouadma, L. Bouadma, and Lila Bouadma. These variations appear across publications and citations.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
15,480 |
| H-index |
58 |
| Paper Count |
268 |
